Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuko Harada

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Pathology, Research and Practice|April 16, 2025
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocationStefano Marletta, Anna Caliò, Francesco Pierconti, et al.
Virchows Archiv : an International Journal of Pathology|May 16, 2020
Rare MDM2 amplification in a fat-predominant angiomyolipomaMaria Del Carmen Rodriguez Pena, Jennifer Gordetsky, Patricia T Greipp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 19, 2020
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1Anna Caliò, Shuko Harada, Matteo Brunelli, et al.
Molecular Cancer Research : MCR|March 5, 2022
Suppression of SIN3A by miR-183 Promotes Breast Cancer MetastasisMackenzie L Davenport, Mara R Davis, Baylea N Davenport, et al.
Journal of Surgical Oncology|May 11, 2011
The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive diseaseShuko Harada, Rosemarie Mick, Robert E Roses, et al.
The British Journal of Dermatology|November 15, 2025
Indeterminate Dendritic Cell Histiocytosis Harboring ETV3::NCOA2 Translocation with Complete Metabolic Response to MEK InhibitionVyshnavi Rallapalle, Jennifer Toral-Orduno, Brinda Shukla, et al.
Cancer Research|February 9, 2021
miR-31 Displays Subtype Specificity in Lung CancerMackenzie L Davenport, John B Echols, Austin D Silva, et al.
Human Pathology|February 8, 2023
Molecular characterization of visible low-grade dysplastic lesions in patients with inflammatory bowel diseaseDeepti Dhall, Elias Makhoul, Roberto Taguibao, et al.
Cancers|May 13, 2023
Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast CarcinomaBrooke B Bartow, Gene P Siegal, Ceren Yalniz, et al.
Molecular Cancer Therapeutics|March 5, 2020
Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating CellsDaisuke Yamashita, Mutsuko Minata, Ahmed N Ibrahim, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Pathology, Research and Practice|April 16, 2025
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocationStefano Marletta, Anna Caliò, Francesco Pierconti, et al.
Virchows Archiv : an International Journal of Pathology|May 16, 2020
Rare MDM2 amplification in a fat-predominant angiomyolipomaMaria Del Carmen Rodriguez Pena, Jennifer Gordetsky, Patricia T Greipp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 19, 2020
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1Anna Caliò, Shuko Harada, Matteo Brunelli, et al.
Molecular Cancer Research : MCR|March 5, 2022
Suppression of SIN3A by miR-183 Promotes Breast Cancer MetastasisMackenzie L Davenport, Mara R Davis, Baylea N Davenport, et al.
Journal of Surgical Oncology|May 11, 2011
The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive diseaseShuko Harada, Rosemarie Mick, Robert E Roses, et al.
The British Journal of Dermatology|November 15, 2025
Indeterminate Dendritic Cell Histiocytosis Harboring ETV3::NCOA2 Translocation with Complete Metabolic Response to MEK InhibitionVyshnavi Rallapalle, Jennifer Toral-Orduno, Brinda Shukla, et al.
Cancer Research|February 9, 2021
miR-31 Displays Subtype Specificity in Lung CancerMackenzie L Davenport, John B Echols, Austin D Silva, et al.
Human Pathology|February 8, 2023
Molecular characterization of visible low-grade dysplastic lesions in patients with inflammatory bowel diseaseDeepti Dhall, Elias Makhoul, Roberto Taguibao, et al.
Cancers|May 13, 2023
Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast CarcinomaBrooke B Bartow, Gene P Siegal, Ceren Yalniz, et al.
Molecular Cancer Therapeutics|March 5, 2020
Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating CellsDaisuke Yamashita, Mutsuko Minata, Ahmed N Ibrahim, et al.
Pageof 9